Mercy Hospital Joplin, formerly known as St. John's Regional Medical Center, is a hospital in Joplin, Missouri, USA. The hospital is famous for suffering devastating damage in the 2011 Joplin tornado. The original storm-ravaged building was demolished in 2013.

During the past decade, St. John's Regional Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. John's Regional Medical Center" #1 sponsor was "NSABP Foundation Inc" with 6 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "Anesiva, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. John's Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "St. John's Regional Medical Center" are "Breast Cancer" (11 trials), "Lung Cancer" (3 trials), "Prostate Cancer" (2 trials), "ABDOMINAL AORTIC ANEURYSMS" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "St. John's Regional Medical Center" in a lesser frequency.

Most popular intervention types in "St. John's Regional Medical Center" are "Drug" (19 trials), "Biological" (7 trials), "Radiation" (7 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "docetaxel" (3 trials), "doxorubicin hydrochloride" (3 trials), "fluorouracil" (3 trials) and "pegfilgrastim" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. John's Regional Medical Center" are 12 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "St. John's Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in St. John's Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. John's Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".